Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health. At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world. For any inquiries, please contact us at: service@credodxbiomed.com
| Website | https://www.credodxbiomed.com/ |
| Revenue | $7 million |
| Employees | 38 (37 on RocketReach) |
| Founded | 2011 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Molecular Diagnostics, Point Of Care Diagnostics, Rapid Diagnostic Tests, Infectious Disease Diagnostics, Animal Health Diagnostics, Rapid Testing, Poc Diagnostics, Diagnostic Devices, In Vitro Diagnostics, Veterinary Diagnostics, Diagnostic Reagents, Medical Diagnostics, Diagnostic Testing, Biomedical Devices, Diagnostic Technology, Cost Effective Diagnostics, Healthcare Diagnostics, Disease Detection, Medical Technology |
| Competitors | Roche, Thermo Fisher Scientific, BD, Cepheid, PerkinElmer, Inc., Siemens Healthineers, Abbott, Bio-Rad Laboratories, QIAGEN, Hologic, Inc. +49 more (view full list) |
Looking for a particular Credo Diagnostics Biomedical employee's phone or email?
The Credo Diagnostics Biomedical annual revenue was $7 million in 2026.
Winston Wong is the Managing Director of Credo Diagnostics Biomedical.
37 people are employed at Credo Diagnostics Biomedical.